Aprecap 125/80 Capsule
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Aprepitant (125mg) + Aprepitant (80mg)
Overview Aprecap 125/80 Capsule
Oncasin 125/80 capsules are a prescription medication to manage nausea and vomiting stemming from chemotherapy or other cancer treatments. This medication works by blocking the signals to the brain that trigger these symptoms. Oncasin 125/80 capsules should be taken as directed by your physician, with or without food. Dosage depends on individual health and response. Continue taking this medication for the prescribed duration; premature discontinuation may lead to symptom recurrence and worsening condition. Inform your healthcare provider of all other medications you are currently using, as interactions are possible. Common side effects include constipation, indigestion, headache, fatigue, decreased appetite, and hiccups; these are usually transient. Report any concerning side effects to your doctor immediately. Drowsiness and dizziness are potential side effects; avoid driving or activities requiring concentration until the medication's effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Consult your physician before use if you are pregnant, planning pregnancy, or breastfeeding.
Uses of Aprecap 125/80 Capsule
Chemotherapy-induced emesis
Major Benefits of Aprecap 125/80 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Aprecap 125/80 Capsules. These capsules can be ingested with or without food; however, consistent daily timing is recommended.
Common Side effects of Aprecap 125/80 Capsule:
- Constipation
- Indigestion
- Headache
- Tiredness
- Loss of appetite
- Hiccup
- Increased liver enzymes
How to use Aprecap 125/80 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Aprecap 125/80 Capsules can be administered with or without food, although consistent timing is recommended.
How Aprecap 125/80 Capsule works:
Each Aprecap 125/80 capsule contains a dual dose of aprepitant, targeting a specific brain neurotransmitter to alleviate chemotherapy-induced nausea and vomiting.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Aprecap 125/80 Capsule may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Aprecap 125/80 Capsule use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
The use of Aprecap 125/80 Capsule while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Aprecap 125/80 Capsules might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
The use of Aprecap 125/80 Capsules is considered safe for individuals with kidney impairment. No alteration of the Aprecap 125/80 Capsule dosage is necessary.
LiverSAFE IF PRESCRIBED
The use of Aprecap 125/80 Capsules in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Aprecap 125/80 Capsule :
Should you forget to take your Aprecap 125/80 Capsule, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Aprecap 125/80 Capsule
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently